Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 (MTHFD1) is a gene located in humans on chromosome 14[4] that encodes a protein, C-1-tetrahydrofolate synthase, cytoplasmic also known as C1-THF synthase, with three distinct enzymatic activities.[5][6][7]
Function
This gene encodes a protein that possesses three distinct enzymatic activities, methylenetetrahydrofolate dehydrogenase (1.5.1.5), methenyltetrahydrofolate cyclohydrolase (3.5.4.9) and formate–tetrahydrofolate ligase (6.3.4.3). Each of these activities catalyzes one of three sequential reactions in the interconversion of 1-carbon derivatives of tetrahydrofolate, which are substrates for methionine, thymidylate, and de novo purine syntheses. The trifunctional enzymatic activities are conferred by two major domains, an aminoterminal portion containing the dehydrogenase and cyclohydrolase activities and a larger synthetase domain.[7][8]
^ abWatkins D, Schwartzentruber JA, Ganesh J, Orange JS, Kaplan BS, Nunez LD, et al. (September 2011). "Novel inborn error of folate metabolism: identification by exome capture and sequencing of mutations in the MTHFD1 gene in a single proband". Journal of Medical Genetics. 48 (9): 590–592. doi:10.1136/jmedgenet-2011-100286. PMID21813566. S2CID9623450.
MacKenzie RE, Mejia N, Yang XM (1989). "Methylenetetrahydrofolate dehydrogenases in normal and transformed mammalian cells". Advances in Enzyme Regulation. 27: 31–39. doi:10.1016/0065-2571(88)90007-6. PMID3074630.
Hol FA, van der Put NM, Geurds MP, Heil SG, Trijbels FJ, Hamel BC, et al. (February 1998). "Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects". Clinical Genetics. 53 (2): 119–125. doi:10.1111/j.1399-0004.1998.tb02658.x. PMID9611072. S2CID42398289.
Schmidt A, Wu H, MacKenzie RE, Chen VJ, Bewly JR, Ray JE, et al. (May 2000). "Structures of three inhibitor complexes provide insight into the reaction mechanism of the human methylenetetrahydrofolate dehydrogenase/cyclohydrolase". Biochemistry. 39 (21): 6325–6335. doi:10.1021/bi992734y. PMID10828945.
Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J (May 2003). "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides". Nature Biotechnology. 21 (5): 566–569. doi:10.1038/nbt810. PMID12665801. S2CID23783563.
Parle-McDermott A, Mills JL, Kirke PN, Cox C, Signore CC, Kirke S, et al. (February 2005). "MTHFD1 R653Q polymorphism is a maternal genetic risk factor for severe abruptio placentae". American Journal of Medical Genetics. Part A. 132A (4): 365–368. doi:10.1002/ajmg.a.30354. PMID15633187. S2CID26023725.
Sun J, Xu Y, Zhu Y, Lu H (October 2006). "Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus". Journal of Endocrinological Investigation. 29 (9): 814–820. doi:10.1007/bf03347376. PMID17114913. S2CID38072740.